Supplementary Figure 2 from Nottingham Clinico-Pathological Response Index (NPRI) after Neoadjuvant Chemotherapy (Neo-Act) Accurately Predicts Clinical Outcome in Locally Advanced Breast Cancer

Supplementary Figure 2. Receiver operating characteristic (ROC) analysis of pathological complete response (pCR), revised pathological TNM stage (yp-TNM stage), Clinical-Pathologic Scoring System (CPS) score and CPS-Oestrogen receptor-histological grade (CPS-EG) were performed for predicting breast cancer specific survival in the training (A), internal validation (B), external validation (C) and combined three cohorts (D).